Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
Heron Therapeutics announced it will report its first quarter 2026 financial results on Monday, May 11, 2026, through a conference call and live webcast. The event, scheduled for 8:30 a.m. ET, will also cover recent business highlights. Interested parties can access dial-in details via a registration link or the Investor Relations section of the company's website.
How this was made

The 30-second read
Why it matters
Earnings results will provide insights into the company's financial health and growth prospects, influencing stock performance.
Market read
The upcoming earnings report is a significant event for HRTX investors and could influence sector sentiment.
What to watch
Market-wide macroeconomic conditions and sector-specific news could overshadow earnings impact.
Background
Heron Therapeutics specializes in developing and commercializing therapies for pain management and other indications.
Ticker impact
Heron Therapeutics upcoming earnings report scheduled for May 11, 2026, is the primary focus.
Potential short-term increase or decrease of 5-10% around the earnings date, contingent on results.
Earnings reports often cause volatility; however, without prior earnings data or consensus estimates, the impact remains uncertain.
Market effects
Potential influence on the biotech and life sciences sectors depending on Heron Therapeutics' results.
Limited, primarily affecting US markets where the company is based.
Minimal, unless results significantly deviate from expectations, prompting broader biotech sector movements.
Counterpoint
Disappointing earnings could lead to a significant decline, suggesting caution in bullish positions.
Key entities
- CompanyHeron Therapeutics
A biotech firm focused on pain management therapies.

